Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.

@article{Minami2012HepatocellularCW,
  title={Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.},
  author={Yasunori Minami and Masatoshi Kudo},
  journal={Digestive diseases},
  year={2012},
  volume={30 6},
  pages={592-7}
}
Among patients with later stage hepatocellular carcinoma (HCC), only 1-12% manifest obstructive jaundice as the initial complaint. Endoscopic retrograde biliary drainage (ERBD) and percutaneous transhepatic biliary drainage (PTBD) are the two main non-surgical treatment options for obstructive jaundice in patients with HCC. ERBD is usually the first-line treatment because of its low hemorrhage risk. Some have reported that the successful drainage rate ranges from 72 to 100%. Mean stent patency… CONTINUE READING